Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic LethalityPaola Sanese, Cristiano Simone|iScience|2020Cited by 25
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistancePaola Sanese, Cristiano Simone|Journal of Experimental & Clinical Cancer Research|2024Cited by 8